China Resources Pharmaceutical Group Ltd. (HK:3320)
:3320
Want to see HK:3320 full AI Analyst Report?
Total Valuation
China Resources Pharmaceutical Group Ltd. has a market cap or net worth of HK$32.79B. The enterprise value is HK$107.06B.
Market CapHK$32.79B
Enterprise ValueHK$107.06B
Share Statistics
China Resources Pharmaceutical Group Ltd. has 6,282,510,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,282,510,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Resources Pharmaceutical Group Ltd.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.57%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)4.57%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee4.02M
Profits Per Employee162.25K
Employee Count72,700
Asset Turnover0.92
Inventory Turnover5.06
Valuation Ratios
The current PE Ratio of China Resources Pharmaceutical Group Ltd. is 3.2. China Resources Pharmaceutical Group Ltd.’s PEG ratio is 0.25.
PE Ratio3.2
PS Ratio0.10
PB Ratio0.49
Price to Fair Value0.49
Price to FCF1.65
Price to Operating Cash Flow1.60
PEG Ratio0.25
Income Statement
In the last 12 months, China Resources Pharmaceutical Group Ltd. had revenue of 292.36B and earned 4.39B in profits. Earnings per share was 0.70.
Revenue292.36B
Gross Profit48.27B
Operating Income13.43B
Pretax Income12.79B
Net Income4.39B
EBITDA17.85B
Earnings Per Share (EPS)0.70
Cash Flow
In the last 12 months, operating cash flow was 21.15B and capital expenditures -3.27B, giving a free cash flow of 17.88B billion.
Operating Cash Flow21.15B
Free Cash Flow17.88B
Free Cash Flow per Share2.85
Dividends & Yields
China Resources Pharmaceutical Group Ltd. pays an annual dividend of HK$0.079, resulting in a dividend yield of 2.95%
Dividend Per ShareHK$0.079
Dividend Yield2.95%
Payout Ratio16.14%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.80
52-Week Price Change9.48%
50-Day Moving Average5.00
200-Day Moving Average4.93
Relative Strength Index (RSI)75.46
Average Volume (3m)13.76M
Important Dates
China Resources Pharmaceutical Group Ltd. upcoming earnings date is Mar 25, 2026, TBA (Not Confirmed).
Last Earnings DateAug 26, 2025
Next Earnings DateMar 25, 2026
Ex-Dividend Date―
Financial Position
China Resources Pharmaceutical Group Ltd. as a current ratio of 1.42, with Debt / Equity ratio of 183.14%
Current Ratio1.42
Quick Ratio1.11
Debt to Market Cap3.72
Net Debt to EBITDA4.16
Interest Coverage Ratio6.11
Taxes
In the past 12 months, China Resources Pharmaceutical Group Ltd. has paid 2.32B in taxes.
Income Tax2.32B
Effective Tax Rate0.18
Enterprise Valuation
China Resources Pharmaceutical Group Ltd. EV to EBITDA ratio is 5.73, with an EV/FCF ratio of 6.04.
EV to Sales0.35
EV to EBITDA5.73
EV to Free Cash Flow6.04
EV to Operating Cash Flow4.99
Balance Sheet
China Resources Pharmaceutical Group Ltd. has HK$34.54B in cash and marketable securities with HK$90.96B in debt, giving a net cash position of -HK$56.42B billion.
Cash & Marketable SecuritiesHK$34.54B
Total DebtHK$90.96B
Net Cash-HK$56.42B
Net Cash Per Share-HK$8.98
Tangible Book Value Per ShareHK$14.52
Margins
Gross margin is 16.51%, with operating margin of 4.59%, and net profit margin of 1.50%.
Gross Margin16.51%
Operating Margin4.59%
Pretax Margin4.38%
Net Profit Margin1.50%
EBITDA Margin6.11%
EBIT Margin4.59%
Analyst Forecast
The average price target for China Resources Pharmaceutical Group Ltd. is HK$6.74, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$6.74
Price Target Upside46.20% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast4.66%
EPS Growth Forecast20.76%